Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05775523
Status:
RECRUITING
Last Update Posted:
2024-01-10
First Post:
2023-03-08
Brief Title:
A Post-Authorisation Safety Study PASS of Patients Treated With Lonapegsomatropin
Sponsor:
Ascendis Pharma Endocrinology Division AS
Organization:
Ascendis Pharma AS
Organization Data
Organization:
Ascendis Pharma AS
Class:
INDUSTRY
Study ID:
ASND0033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascendis Pharma Endocrinology Division AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None